A massive global study led by researchers at the University of Melbourne and Cancer Council Victoria has confirmed that the risk of developing breast cancer from some relatively rare genetic changes is similar to that from the more common BRCA1 and BRCA2 mutations.
New research has revealed women with a strong genetic predisposition to breast cancer who take the cancer prevention tablet tamoxifen after their first tumour, have a substantially reduced risk of developing a new breast cancer.
An international team of researchers led by the University of Melbourne has used new technology to fast track the discovery of a breast cancer risk gene which could assist in the discovery of other cancer genes.
Mothers, sisters and daughters from breast cancer families with known genetic mutations do not all share the same high risk of developing the disease, according to a new international study involving the University of Melbourne.
Women with a strong family history of breast cancer, but no genetic link, are not consistent in how they perceive their risk or in their efforts to manage the risk, leading some women to not adequately access breast cancer services, a University of Melbourne study has found.